Strategies for Conjugation of Biomolecules to Nanoparticles as Tumor Targeting Agents
- 17 December 2019
- journal article
- review article
- Published by Bentham Science Publishers Ltd. in Current Pharmaceutical Design
- Vol. 25 (37) , 3917-3926
Abstract
Combination of nanotechnology, biochemistry, chemistry and biotechnology provides the opportunity to design unique nanoparticles for tumor targeting, drug delivery, medical imaging and biosensing. Nanoparticles conjugated with biomolecules such as antibodies, peptides, vitamins and aptamer can resolve current challenges including low accumulation, internalization and retention at the target site in cancer diagnosis and therapy through active targeting. In this review, we focus on different strategies for conjugation of biomolecules to nanoparticles such as inorganic nanoparticles (iron oxide, gold, silica and carbon nanoparticles), liposomes, lipid and polymeric nanoparticles and their application in tumor targeting.Keywords
This publication has 96 references indexed in Scilit:
- Fabrication of tumor necrosis factor-related apoptosis inducing ligand (TRAIL)/ALG modified CaCO3 as drug carriers with the function of tumor selective recognitionJournal of Materials Chemistry B, 2013
- Self-Assembled Multivalent DNA Nanostructures for Noninvasive Intracellular Delivery of Immunostimulatory CpG OligonucleotidesACS Nano, 2011
- Aromatic Aldehyde and Hydrazine Activated Peptide Coated Quantum Dots for Easy Bioconjugation and Live Cell ImagingBioconjugate Chemistry, 2011
- Multi-stage delivery nano-particle systems for therapeutic applicationsBiochimica et Biophysica Acta (BBA) - General Subjects, 2011
- Local Release of Highly Loaded Antibodies from Functionalized Nanoporous Support for Cancer ImmunotherapyJournal of the American Chemical Society, 2010
- Thiol–Ene Click ChemistryAngewandte Chemie International Edition, 2010
- DNA Nanotubes as Combinatorial Vehicles for Cellular DeliveryBiomacromolecules, 2008
- Nanoparticle therapeutics: an emerging treatment modality for cancerNature Reviews Drug Discovery, 2008
- In VivoTumor Cell Targeting with “Click” NanoparticlesBioconjugate Chemistry, 2008
- Directional conjugation of antibodies to nanoparticles for synthesis of multiplexed optical contrast agents with both delivery and targeting moietiesNature Protocols, 2008